[Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid; D013237:Stereoisomerism
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid; D004298:Dopamine